Characterisation of a partially purified human menopausal gonadotropin preparation

Journal of Clinical Research

Volumn 4, Issue 27-34, 2001, Pages 27-34

  Giudice, E ^a   Crisci, C ^a   Altarocca, V ^a   O'Brien, M ^a  

^a Ist di Ricerca Cesare Serono SpA   (Italy)

Author keywords

Composition; Human chorionic gonadotropin; Human follicle stimulating hormone; Human menopausal gonadotropin; Purity Specific activity

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; MENOGON HP; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONTENT;

EID: 0034870506     PISSN: 13695207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Human follicle-stimulating hormone produced by recombinant DNA technology: A review for clinicians
2. A prospective, randomized, assessor-blind multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon versus metrodin) in in-vitro fertilization
3. Recombinant versus urinary follicle-stimulating hormone for ovarian stimulation in assisted reproduction cycles
4. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. An improved bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations
7. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: A dose-finding study
8. Premature progesterone elevation spares blastulation but not pregnancy rates in in-vitro fertilization with coculture
9. Recombinant follicle-stimulating hormone: Development of the first biotechnology product for the treatment of infertility
10. Composition of commercial gonadotropin preparations extracted from human postmenopausal urine: Characterization of nongonadotropin proteins
11. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations
12. Human chorionic gonadotropin contributes to the bioactivity of Pergonal